Literature DB >> 6176882

Sensitivity and resistance of human tumor cells to interferon and rIn . rCn.

S L Lin, J J Greene, P O Ts'o, W A Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6176882     DOI： 10.1038/297417a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  The potential of interferons in malignant disease.

Authors:  K Okita; T Kaneko
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

2.  Identification of interferon-modulated proliferation-related cDNA sequences.

Authors:  D A Kulesh; D R Clive; D S Zarlenga; J J Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 3.  Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes.

Authors:  M Kumar; G G Carmichael
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

4.  Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.

Authors:  R S Dick; H R Hubbell
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Comparative study of the antitumor effect of two types of murine recombinant interferons, (beta) and (gamma), against B16-F10 melanoma.

Authors:  M Sakurai; M Iigo; T Tamura; A Otsu; Y Sasaki; H Nakano; K Nakagawa; K Minato; Y Ohe; N Saijo
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells.

Authors:  Wai Hoe Lau; Xiphias Ge Zhu; Shamaine Wei Ting Ho; Shu Chun Chang; Jeak Ling Ding
Journal:  Oncotarget       Date:  2017-05-16

7.  Interferon-specific effects on protein synthesis in P3HR-1 cells.

Authors:  T Leanderson; S Sundström; I L Mårtensson; T Ny; E Lundgren
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

8.  Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts.

Authors:  R Berman; G G Steel
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.